Clinical trial
Drug Use-Results Survey of Betanis Tablets 25 and 50 mg
NCT01919047 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Drug Use-Results Survey of Betanis Tablets 25 and 50 mg
- Lead sponsor
- Astellas Pharma Inc
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2012
- Completion date
- July 31, 2014
- Enrollment
- 10,711 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
overactive bladder